KRRO
Korro Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.13
+4.39%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.25
- Revenue estimate
- $187.5K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.07
- EPS estimate
- -$1.34
- Revenue actual
- $1.5M
- Revenue estimate
- $214.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -29.0%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $15
- PT range
- $15 – $15
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026